Cuba Ventures Announces Tim Fernback as CFO

Cuba Ventures Corp. is pleased to announce that the Company has appointed Tim Fernback MBA, CPA, CMA as its Chief Financial Officer (CFO). In addition, each one of the Company’s directors: Steve Marshall, James Pettit, Donald Huston, Tim Fernback and Amanda Chow have been reelected to the board of directors of the Company at the Company's annual general meeting of shareholders held in Vancouver on December 16th, 2016. Steve Marshall has consented to act as CEO, James Pettit to act as President and Tim Fernback has consented to act as CFO.

Tim Fernback has over twenty years of experience financing both private and public micro-capitalization companies in Canada. Mr. Fernback ran the technology consulting practice for Discovery Capital Corporation, a prominent British Columbia venture capital firm specializing in financing and consulting to technology-based start-up ventures.

Mr. Fernback went on to run the Investment Banking and Corporate Finance Departments for one of the oldest and most respected Western Canadian-based brokerage firms, Wolverton Securities Ltd.

Currently, Mr. Fernback provides strategic consulting services including business planning and analysis, supply chain management, capital markets support, corporate finance, and mergers and acquisitions services as Regional Director of The CFO Centre Limited, the world's largest provider of permanent, part-time and interim CFO services to growing companies. Mr. Fernback has served as both a Director and Officer of several public companies.

Mr. Fernback is a graduate of McMaster University where he studied molecular biology and biochemistry, and a graduate of the University of British Columbia, where he completed an MBA with a concentration in Finance.

He is an active member of the Chartered Professional Accountants of British Columbia and is an active member of many industry and trade organizations in Canada.

Cuba Ventures also announces that pursuant to its stock option plan, the Company has granted incentive stock options to its various directors, officers, employees and consultants to purchase up to an aggregate of 1,039,500 common shares in the capital stock of the Company, exercisable for a period of 5 years, at a price of $0.05 per share.